Literature DB >> 20073608

Variation in human erythrocyte membrane unsaturated Fatty acids: correlation with cardiovascular disease.

Jorge L Sepulveda1, Yvette C Tanhehco, Monica Frey, Lida Guo, Lorna J Cropcho, K Michael Gibson, Harry C Blair.   

Abstract

CONTEXT: Whether cell membrane fatty acid (FA) composition is a useful indicator of vascular disease is unclear.
OBJECTIVE: To study variation of erythrocyte (RBC) membrane FA in samples from healthy volunteers, hospitalized patients, and cardiac troponin I-elevated patients with myocardial damage without a priori assumptions as to FA composition.
DESIGN: We separated FAs extracted from RBCs by gas chromatography and identified them by mass spectrometry. Fatty acids with abundance greater than 1% of total were quantified and compared: hexadecanoic (C16:0), octadecadienoic (C18:2), cis- and trans-octadecenoic (C18:1), and eicosatetraenoic (C20:4) acids. Deuterated standards established proportionality of FA recovery. The cis- and trans-C18:1 identification was verified by comparison with standards.
RESULTS: In troponin-positive samples, C18:2 to C18:1 ratios were increased 30% compared with healthy controls or with random patient samples. Erythrocyte trans-C18:1 had a wide variation, approximately 10-fold, in all groups but without differences between groups. Replicates showed that the wide range of RBC trans-FA load is not due to analytic variation. In healthy subjects, the RBC content of lower- molecular weight FAs (C16-C18) correlated with serum low-density lipoprotein cholesterol, but despite the established relationship between dietary trans-FA and increased low-density lipoprotein cholesterol, lipid profiles had no correlation with RBC trans-FA content.
CONCLUSIONS: Erythrocyte accumulation of unsaturated FA may be a useful indicator of vascular disease, whereas the wide range in trans-FAs suggests that both diet and genetic variation affect RBC trans-FA accumulation. Unsaturated FAs increase membrane fluidity and may reflect a natural response to subclinical vascular changes, which may in turn reflect increased risk of clinical disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20073608     DOI: 10.5858/2008-0795-OAR1.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates.

Authors:  Harry C Blair; Jorge Sepulveda; Dionysios J Papachristou
Journal:  Vascul Pharmacol       Date:  2015-06-30       Impact factor: 5.773

2.  The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative.

Authors:  Tonya S Orchard; Steven W Ing; Bo Lu; Martha A Belury; Karen Johnson; Jean Wactawski-Wende; Rebecca D Jackson
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

3.  Elaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn(2+) in human macrophages.

Authors:  Janelle R Zacherl; Irina Tourkova; Claudette M St Croix; Lisa J Robinson; Octavia M Peck Palmer; Stephanie J Mihalik; Harry C Blair
Journal:  J Cell Biochem       Date:  2015-04       Impact factor: 4.429

Review 4.  Genetic variation in lipid desaturases and its impact on the development of human disease.

Authors:  Diana M Merino; David W L Ma; David M Mutch
Journal:  Lipids Health Dis       Date:  2010-06-18       Impact factor: 3.876

5.  Transcriptional regulation of Δ6-desaturase by peroxisome proliferative-activated receptor δ agonist in human pancreatic cancer cells: role of MEK/ERK1/2 pathway.

Authors:  Maryam Darabi; Shima Byagowi; Shabnam Fayezi; Masoud Darabi; Shahab Mirshahvaladi; Mehdi Sahmani
Journal:  ScientificWorldJournal       Date:  2013-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.